• Pre-course images: Initial assessment will include a few image submissions required prior to the start of the course and in the participant’s focus area(s). The pre-course requirement is used to review current experience level. 

• Post-course images: The required images must be submitted within 90 days (3 months) following the conclusion of the course, tailored to each participant’s selected focus area(s). Please note, these additional images will come from different patients than those submitted during the pre-course review. 

• Participants who do not complete the required submissions within the designated timeframe will not receive a Certificate of Competency.

• Image requirements and overall instructions will be emailed after registration is confirmed. 

Upon completion of this course, participants should be able to:  

• Evaluate the uterus and its pathologies, including various types of fibroids and adenomyosis.  

• Identify advanced 3D ultrasound techniques and measure Müllerian anomalies that influence pregnancy outcomes and distinguish bicornuate from septate uterus configurations.   

• Recognize and differentiate adnexal physiological and pathological changes, including ovarian cysts and masses, and tubal pathology.  

• Assess ovarian reserve with ultrasound.    

• Describe sonohysterogram techniques for evaluating uterine cavity abnormalities and tubal patency with HyCoSy.  

• Acquire increased knowledge in diagnosing early pregnancy complications, such as ectopic pregnancies, missed abortions, and subchorionic hematomas, with precision and confidence.    

• Evaluate the pelvic floor muscles and its changes in pelvic floor pathologies. 

Additional Credit Information  

• American Registry for Diagnostic Medical Sonography (ARDMS) accepts AMA PRA Category 1 CME Credit(s)™. 

In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, the American Institute of Ultrasound in Medicine (AIUM) requires those in control of educational content to disclose their financial relationships with ineligible companies* within the prior 24 months. Individuals must disclose all financial relationships with ineligible companies*, regardless of the amount and regardless of their view of the relevance of the relationship to education.   

* Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. For specific examples of ineligible companies, visit accme.org/standards.   

As an accredited provider, the AIUM must collect information from all planners, faculty, and others in the planning and control of continuing medical education (CME) activities to disclose all of their financial relationships with ineligible companies within the prior 24 months. There is no minimum financial threshold; individuals must disclose all financial relationships, regardless of the amount, in ineligible companies. Individuals must disclose financial relationships with ineligible companies regardless of their view of the relevance of the relationship to the education.    

The AIUM has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair balanced, independent, and free of commercial bias. Conflicts, if any, are resolved through one or more processes. All relevant conflicts pertaining to this activity will be mitigated.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the AIUM.  

The following faculty/planners of this educational activity have disclosed the following financial relationships with ineligible companies:   

Laura Berg, BS, RDMS, RVT – Consultant/Advisory Board: Sonio  

The following faculty/planners of this educational activity have no relevant financial relationships(s) with ineligible companies to disclose.   

Laura Detti, MD